.

The next instalment in the Head Start webinar series is fast approaching.

This educational, non-promotional webinar is organised and funded by Teva UK Limited.  It is open to consultants, nurses, GPs, other healthcare professionals and payers from the UK with an interest in headache and migraine.

Details of this upcoming webinar can be found below.  If you're interested in attending the evening webinar, we recommend registering now to confirm your space at these highly sought after events.

We hope that you can join us and help make the meeting as interactive as possible.

.

Optimising Headache Pathways: Wednesday 11 May 2022 | 18:30 – 19:30

You are welcome to join us at our live webinar with audience collaboration and interactive Q&A.

Learn more about headache pathways, discover why optimising headache services is so important and get the opportunity to discuss specific scenarios with those who have already setup their own pathways.

Dr Niranjanan Nirmalananthan (Chair)

Consultant Neurologist, St George's University Hospitals NHS Foundation Trust

Ms Hannah Verghese

Programme Manager, The National Neurosciences Advisory Group

Dr Richard Wood

GP Headache Specialist, Oxford University Hospitals Trust

Ms Anne-Marie Logan

Consultant Physiotherapist in Headache, St George's University Hospitals NHS Foundation Trust

.

The webinar agenda is subject to change. Please refer back to this page for an up-to-date agenda.

You will receive further details once your registration is confirmed.

.

If you have any questions about the Head Start Webinars or wish to cancel your attendance, please contact us on headstart@violicom.co.uk

If you have a specific question about our products or services, please use the main Teva contact us information to direct your query.

If you want to report an adverse event or side effect relating to one of our products: Reporting forms and information can be found at www.mhra.gov.uk/yellowcard (UK) or www.hpra.ie (ROI). Adverse events should also be reported to Teva using the Reporting Side Effects Form or by email uk.safety@tevauk.com.